Nienke Visser
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Multi-omic profiling and preclinical efficacy of fratricide-driven, unedited CD7 CAR-T cells in T-cell leukemia.
Journal: Journal of translational medicine
Published: October 07, 2025
High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosis.
Journal: Immunologic research
Published: April 10, 2025
K12-ligand-based CAR T cell therapy for CD7-positive T cell malignancies.
Journal: Molecular therapy. Oncology
Published: December 20, 2024
Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 17, 2024
Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity.
Journal: Frontiers in immunology
Published: September 01, 2023
Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine.
Journal: International journal of molecular sciences
Published: January 21, 2021
The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer.
Journal: International journal of molecular sciences
Published: September 14, 2020
Oxygenated hypothermic machine perfusion after static cold storage improves endothelial function of extended criteria donor livers.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: November 20, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026